COVID-19: combining antiviral and anti-inflammatory treatments

Item Type:

Publication

Title

COVID-19: combining antiviral and anti-inflammatory treatments

Description

Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are characterised by an overexuberant inflammatory response and, for SARS, viral load is not correlated with the worsening of symptoms.

The article received comments and an author's reply:
  1. Favalli, Ennio G., Martina Biggioggero, Gabriella Maioli, and Roberto Caporali. 2020. "Baricitinib for COVID-19: a suitable treatment?" The Lancet Infectious Diseases.
  2. Richardson, Peter J., Mario Corbellino, and Justin Stebbing. 2020. "Baricitinib for COVID-19: a suitable treatment? - Authors' reply." The Lancet Infectious Diseases.

Date Last Updated (Year-Month-Day)

2020-02-27

Citation

Stebbing, Justin, Anne Phelan, Ivan Griffin, Catherine Tucker, Olly Oechsle, Dan Smith, and Peter Richardson. 2020. "COVID-19: combining antiviral and anti-inflammatory treatments." The Lancet Infectious Diseases.

Accessibility

Free online on Lancet site.

Share this page: